The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer

J Yuan, L Yang, Z Li, H Zhang, Q Wang… - Frontiers in …, 2023 - frontiersin.org
Endocrine therapy is the prominent strategy for the treatment of hormone-positive breast
cancers. The emergence of resistance to endocrine therapy is a major health concern …

Multi-omics analysis of DNA replication-associated primase polymerase (PRIMPOL) in pan-cancer: a potential target for prognosis and immune response

L Deng, A Thakur, J Peng, L Song, Z Li - European Journal of Medical …, 2023 - Springer
Background It is critical to understand the mechanisms of human cancers in order to develop
the effective anti-cancer therapeutic strategies. Recent studies indicated that primase …

New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis

M Sadrkhanloo, MDA Paskeh, M Hashemi… - … -Research and Practice, 2023 - Elsevier
Osteosarcoma (OS) is a malignant bone carcinoma that affects people in childhood and
adulthood. The heterogeneous nature and chromosomal instability represent certain …

METTL3-mediated m6A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis

Z Zhou, Y Cao, Y Yang, S Wang, F Chen - Epigenetics, 2023 - Taylor & Francis
Doxorubicin (DOX) resistance in breast cancer (BC) poses a huge challenge for the
therapeutic effect on BC. Lnc KCNQ1OT1 play crucial roles in chemotherapy resistance …

[HTML][HTML] Liquid-liquid phase separation-related lncRNA prognostic signature and ZNF32-AS2 as a novel biomarker in hepatocellular carcinoma

W Peng, Y Li, B Cheng, M Cao, L Liu, Y Yang… - Computers in Biology …, 2024 - Elsevier
Background Liquid-liquid phase separation (LLPS) enhances oncogenic signaling
pathways and advances cancer progression, and has been proposed as a promising cancer …

A prognostic exosome-related long non-coding RNAs risk model related to the immune microenvironment and therapeutic responses for patients with liver …

Y Yue, J Tao, D An, L Shi - Heliyon, 2024 - cell.com
Background Liver hepatocellular carcinoma (LIHC) is the third largest cause of cancer
mortality. Exosomes are vital regulators in the development of cancer. However, the …

LncRNA FAM83A-AS1 promotes epithelial–mesenchymal transition of pancreatic cancer cells via Hippo pathway

H Wang, Y Ding, Q Zhu, Z Yu, Q Wang, A Gong, M Xu - Cell Cycle, 2023 - Taylor & Francis
ABSTRACT Background Long non-coding RNAs (lncRNAs) have been proved to play a vital
role in pancreatic cancer (PC). However, the role of lncRNA FAM83A-AS1 in PC remains …

T Cell and Natural Killer Cell Membrane-Camouflaged Nanoparticles for Cancer and Viral Therapies

F Ozsoy, M Mohammed, N Jan, E Lulek… - ACS Applied Bio …, 2024 - ACS Publications
Extensive research has been conducted on the application of nanoparticles in the treatment
of cancer and infectious diseases. Due to their exceptional characteristics and flexible …

CircLDLRAD3 inhibits Oral squamous cell carcinoma progression by regulating miR‐558/Smad4/TGF‐β

X Zhang, GY Guo, RY Liu, T Wu… - Journal of Cellular …, 2023 - Wiley Online Library
Oral squamous cell carcinoma (OSCC) is a malignant neoplasm with high mortality and
morbidity. The role of circRNA and its molecular mechanism in OSCC remains largely …

Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics

K Liu, H Chen, Y Li, B Wang, Q Li, L Zhang, X Liu… - Cancer Letters, 2024 - Elsevier
Autophagy, a self-digestion mechanism, has emerged as a promising target in the realm of
cancer therapy, particularly in bladder cancer (BCa), a urological malignancy characterized …